Drawing for MECHANOSTICS

USPTO serial 98679322

MECHANOSTICS

Reviewed by CopyMark Law Group

Reg. 8209395Status 700Registered
Filing date
Status date
Registration date
Apr 14, 2026
Examiner
DEAN, JULES J.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MECHANOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Geza C. Ziegler Jr.

Geza C. Ziegler Jr. ZIEGLER IP LAW GROUP, LLC.2000 POST ROADSUITE 205FAIRFIELD, CT 06824

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for word processing in the field of medicine, healthcare, genetics, foods and dietary supplements; Downloadable computer software for database management; Scientific instruments and laboratory research apparatus for the determination of DNA sequence, RNA transcript and protein sequence, namely DNA or RNA sequencing instruments for long-read genome sequencing, short-read targeted genome sequencing and whole genome sequencing for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus for the determination of DNA sequence, RNA transcript and protein sequence, namely instruments for sequencing by synthesis, exome, transcriptome sequencing and epigenetic profiling for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely instruments for DNA methylation sequencing based on ChIP-Seq, methyl-seq, nano pore and epigenetic profiling for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely DNA sequencing instruments for the determination of targeted/whole genome SNP genotypes and other genomic variants/rearrangements for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely hybridization capture apparatus, including bead-based and fixed-array capture systems for pre-defined SNP genotyping for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific instruments and laboratory research apparatus, namely protein sequencing and transcriptomic analysis instruments utilizing RNA sequencing-based readouts, immunoassay-based technologies, mass spectrometry (MALDI-TOF), Edman Degradation, high-performance liquid chromatography (HPLC) for analysis of biomolecules in multi-modal biomarker discovery, genomics, proteomics and epigenetic biomarkers and validation scientific research studies, for identification of biomolecules in scientific research and related to multi-factorial analysis of scientific data, and for detection of scientific data, namely, biomedical data by use of semantic discovery engines used by biomedical researchers; Scientific apparatus and instruments for analyzing DNA, RNA and protein using a downloadable computer software analytics platform for analysis of scientific data; electronic data carriers containing data in the nature of stored typographic typefaces; ComputersACTIVE—
010Medical diagnostic apparatus for detecting biomarkers; Apparatus for blood analysis.ACTIVE—
035Data processing services in the field of healthcare; business administration services in the field of healthcareACTIVE—
042Scientific research; clinical research in the field of medicine, healthcare, genetics, nutrition, phenotypic, dietary, wellness, breast cancer, ontologies; Scientific research in the nature of conducting clinical trials for others; biological research; medical research; providing information about scientific clinical studies via an interactive website; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research in the field of gene therapy; genetic engineering services, namely, scientific research in the field of genetic engineering; human biomedical genetic research; scientific research in the field of genetics and genetic engineering; medical research; electronic data storage; design and development of computer software systems comprised of computer software platforms and computer software applications for data input, output, processing, display and storageACTIVE—
044Healthcare; Healthcare consultancy; healthcare services; Providing healthcare information; healthcare advisory services in the field of medical treatment, wellness, nutrition; clinical health counselling services; medical health assessment services; medical and healthcare services in the fields of DNA, genetics and genetic testing; genetic testing for medical purposes; healthcare services, namely, monitoring of patients with disorders; individual medical counseling services provided to patients; medical care and analysis services relating to treatment of patients with conditions, namely, cancer, diabetes, and bipolar disorder; health counseling; health screening in the fields of oncology, neuropsychiatric and metabolic disease; providing news and information in the field of medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 14, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 14, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 23, 2026ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jan 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 15, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 19, 2025ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Dec 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 10, 2025DOCKASSIGNED TO EXAMINER—
Nov 6, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Jul 11, 2025PETGPETITION TO REVIVE-GRANTED—
Jul 11, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Jun 16, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 16, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 28, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2025DOCKASSIGNED TO EXAMINER—
Jan 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance